PremiumThe FlyBioRestorative Therapies announces new data on BRTX-100 presented at ORS 2025 BioRestorative Therapies granted European patent protecting ThermoStem program BioRestorative Therapies Q3 2024 Financial Update PremiumThe FlyBioRestorative Therapies to present new data at ORS PSRS symposium BioRestorative Therapies receives expanded tissue license from NYSDOH BioRestorative Therapies receives patent allowance for TheroStem PremiumThe FlyBioRestorative Therapies reports Q1 EPS (33c) vs. ($1.93) last year BioRestorative Therapies regains compliance with Nasdaq listing rule BioRestorative in discussions for potential license agreement for ThermoStem